Skip to content
Est. 1998 proudly celebrating our 27th year of championing American business
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Bone Biologics Corp

  • BURLINGTON, Massachusetts
  • Public · NASDAQ: BBLG
  • 2 employees
$2.2MMarket cap
$1.1BRevenue · FY2020
-$3.1MNet income
2Employees
BBLGNASDAQ
2015IPO

About Bone Biologics Corp

Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2020
$1.1B
Net income
-$3.1M
Total assets
$5.8M
Market cap
$2.2M

Source: SEC EDGAR · updated Jun 8, 2026

NASDAQ: BBLG

15-minute delayed · data by Polygon.io

Market cap
$2.2M
Open
Day range
Prev close
Volume
IPO date
Nov 27, 2015

Market data by Polygon.io · prices are 15-minute delayed

No reviews yet. Be the first to review Bone Biologics Corp.

Write a review
Explore

Similar companies

Browse all →